FDA & Japanese Health Ministry (厚生労働省) To Develop Joint iPS cell clinical rules by 2015 while first human studies to begin earlier in 2014

In a rare sign of stem cell international regulatory unity, the Japanese Health Ministry (厚生労働省) and the US FDA have agreed to develop a joint, unified regulatory framework for clinical studies of human iPS cells for use in treating retinal diseases. Presumably the rules would also guide clinical use of iPS cells to treat other …

FDA & Japanese Health Ministry (厚生労働省) To Develop Joint iPS cell clinical rules by 2015 while first human studies to begin earlier in 2014 Read More »